Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Merville

Showing results (131-140 of 138) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 138 results.
Oncogene|May 10, 2006
Transcriptional activation of cyclooxygenase-2 by tumor suppressor p53 requires nuclear factor-kappaBV Benoit, E de Moraes, N A Dar, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 25, 2015
Daclizumab Versus Rabbit Antithymocyte Globulin in High-Risk Renal Transplants: Five-Year Follow-up of a Randomized StudyR Hellemans, M Hazzan, D Durand, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 27, 2015
Fibrosis progression according to epithelial-mesenchymal transition profile: a randomized trial of everolimus versus CsAL Rostaing, A Hertig, L Albano, et al.
Journal of Transplantation|May 16, 2014
Three-year outcomes in kidney transplant patients randomized to steroid-free immunosuppression or steroid withdrawal, with enteric-coated mycophenolate sodium and cyclosporine: the infinity studyA Thierry, G Mourad, M Büchler, et al.
Transplantation Proceedings|November 23, 2006
Tolerability of enteric-coated mycophenolate sodium to 1 year in combination with cyclosporine and corticosteroids in renal transplant recipientsL Rostaing, G Mourad, N Kamar, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 31, 2025
Determinants of virological outcomes in kidney transplant recipients treated with maribavir for refractory cytomegalovirus infectionN Kasriel, S Alain, I Benotmane, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 9, 2016
Genome-Wide Association Study of Acute Renal Graft RejectionL Ghisdal, C Baron, Y Lebranchu, et al.
Transplantation|October 2, 2001
Induction versus noninduction in renal transplant recipients with tacrolimus-based immunosuppressionG Mourad, V Garrigue, J P Squifflet, et al.
Pageof 14

Showing results (131-140 of 138) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 138 results.
Oncogene|May 10, 2006
Transcriptional activation of cyclooxygenase-2 by tumor suppressor p53 requires nuclear factor-kappaBV Benoit, E de Moraes, N A Dar, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 25, 2015
Daclizumab Versus Rabbit Antithymocyte Globulin in High-Risk Renal Transplants: Five-Year Follow-up of a Randomized StudyR Hellemans, M Hazzan, D Durand, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 27, 2015
Fibrosis progression according to epithelial-mesenchymal transition profile: a randomized trial of everolimus versus CsAL Rostaing, A Hertig, L Albano, et al.
Journal of Transplantation|May 16, 2014
Three-year outcomes in kidney transplant patients randomized to steroid-free immunosuppression or steroid withdrawal, with enteric-coated mycophenolate sodium and cyclosporine: the infinity studyA Thierry, G Mourad, M Büchler, et al.
Transplantation Proceedings|November 23, 2006
Tolerability of enteric-coated mycophenolate sodium to 1 year in combination with cyclosporine and corticosteroids in renal transplant recipientsL Rostaing, G Mourad, N Kamar, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 31, 2025
Determinants of virological outcomes in kidney transplant recipients treated with maribavir for refractory cytomegalovirus infectionN Kasriel, S Alain, I Benotmane, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 9, 2016
Genome-Wide Association Study of Acute Renal Graft RejectionL Ghisdal, C Baron, Y Lebranchu, et al.
Transplantation|October 2, 2001
Induction versus noninduction in renal transplant recipients with tacrolimus-based immunosuppressionG Mourad, V Garrigue, J P Squifflet, et al.
Pageof 14